Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.44 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7322797 | 0.81 | L3MBTL1 (0.55) | L3MBTL1KMT2AALDH1A1MAPK1LMNA | |
| SCHEMBL28021753 | 0.81 | L3MBTL1 (0.55) | L3MBTL1KMT2AALDH1A1MAPK1LMNA | |
| SCHEMBL1107142 | 0.80 | CYP4F2 (0.66) | RAB9AMAPTNPC1L3MBTL1HPGD | |
| Ammonia Solution, Strong SCHEMBL28854172 | 0.79 | CYP4F2 (0.63) | RAB9AMAPTNPC1L3MBTL1HPGD | |
| SCHEMBL27598761 | 0.79 | L3MBTL1 (0.49) | CYP1A2CYP2C9RAB9AMAPTNPC1 | |
| SCHEMBL6455146 | 0.78 | KMT2A (0.50) | CYP1A2CYP2C9RAB9AMAPTNPC1 | |
| Nitrogen SCHEMBL27903948 | 0.77 | CYP4F2 (0.61) | RAB9AMAPTNPC1L3MBTL1HPGD | |
| Potassium Ion SCHEMBL4444178 | 0.76 | CTBP2 (0.52) | RAB9ANPC1L3MBTL1HPGDKMT2A | |
| SCHEMBL15804409 | 0.76 | CYP4F2 (0.59) | RAB9AMAPTNPC1L3MBTL1HPGD | |
| SCHEMBL28561195 | 0.75 | L3MBTL1 (0.50) | RAB9AMAPTNPC1L3MBTL1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | CANO IVAN COLLADO | 2009-03-05 | — | — | US | disclosed |
| US-7304062-B2 | Peroxisome proliferator activated receptor alpha agonists | ELI LILLY AND COMPANY (US) | 2007-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | PPARG, PPARA, PPARD | CYP1A2 452/4885CYP2C9 702/4885RAB9A 4445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.